Physician profile
Allen Cheng
NPI 1043537707
$9,003.68
in general payments reported to CMS, 2019-2025
14 companies · $2,281 in 2025
The $2,281 reported for 2025 was more than what 91% of Oral & Maxillofacial Surgery providers received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2020: $222 · 2021: $666 · 2022: $307 · 2023: $2,656 · 2024: $2,590 · 2025: $2,281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,056 · Education: $2,388 · Travel and Lodging: $1,967 · Entertainment: $70.00 · Gift: $45.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,056.37 |
| Education | $2,387.85 |
| Travel and Lodging | $1,966.82 |
| Entertainment | $70.00 |
| Gift | $45.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $2,164.38 | 2019-2024 | Floseal |
| Stryker Corporation | $1,938.57 | 2019-2025 | Na, Vsp System, Vsp Cranial, Patient-Fitted Tmj Reconstructive Prosthesis System |
| Medical Device Business Services, INC. | $1,585.87 | 2019-2024 | Trumatch, Na |
| Straumann USA LLC | $976.20 | 2020-2025 | |
| Depuy Synthes Sales INC. | $884.44 | 2021-2025 | Trumatch, Matrixmandible |
| Kls-Martin L.P. | $481.69 | 2020-2023 | |
| Axogen | $350.27 | 2023-2024 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Ha+ Nerve Protector |
| Nobel Biocare USA | $250.19 | 2019-2023 | Nobelactive |
| Acera Surgical, INC. | $158.06 | 2025 | Restrata Wound Matrix |
| Keystone Dental INC. | $70.00 | 2023 | |
| Ethicon US, LLC | $52.00 | 2022 | |
| Solventum Corporation | $44.63 | 2024 | V.A.C. Veraflo, Activ.A.C., Prevena |
| Left Coast Surgical INC | $29.92 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $17.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.